Digoxin Medulloblastoma Study

Clinical trial NCT06701812 · RECRUITING

Trial details

NCT number: NCT06701812
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Medulloblastoma Medulloblastoma, Non-WNT/Non-SHH

Start date: 2026-01-15
Primary completion: 2027-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.